Troponin for the estimation of infarct size: what have we learned?Jonas Hallén
Department of Cardiology, Oslo University Hospital Ullevaal, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
Cardiology 121:204-12. 2012
..Early data are promising and indicate that cardiac troponins could provide useful information for early risk assessment that is complementary to the determination of cardiac function and volumes...
- Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction
Jonas Hallén
Division of Cardiology, Oslo University Hospital, Aker, Oslo, Norway
Am J Cardiol 104:1472-7. 2009
..In conclusion, a single-point cTnI measurement taken early after a first-time STEMI is a useful marker for infarct size and might also supplement early CMR evaluation in prediction of infarct size at 4 months...
- Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction
Jonas Hallén
Department of Cardiology, Oslo University Hospital, Faculty of Medicine, University of Oslo, Norway
Acute Card Care 13:48-51. 2011
..We aimed to explore whether cTnI values were associated with presence of MVO independently of infarct size in STEMI patients receiving pPCI...
- A window into your heart: taking cardiac troponin to the next level
Jonas Hallén
Department of Cardiology, Oslo University Hospital, Aker and Ullevål, Oslo, Norway
Biomark Med 4:889-94. 2010
..Sampling of troponin in such patient populations may allow for more refined risk stratification and, importantly, help clinicians individualize care beyond what is currently possible...
- Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease
Jonas Hallén
Department of Cardiology, Oslo University Hospital, Aker and Ullevaal, Oslo, Norway
Scand J Urol Nephrol 45:151-8. 2011
....
- Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction
Jonas Hallén
Department of Cardiology, Oslo University Hospital, Aker, Trondheimsveien 235, Oslo, Norway
Heart 96:1892-7. 2010
..To investigate the ability of cardiac troponin I (cTnI) to predict functional recovery and left ventricular remodelling following primary percutaneous coronary intervention (pPCI) in ST-elevation myocardial infarction (STEMI)...
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitusJonas Hallén
Department of Cardiology, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
Cardiovasc Diabetol 9:52. 2010
..Accordingly, we aimed to understand the prevalence, determinants, and prognostic implications of cardiac troponin T (cTnT) elevations measured with a high-sensitivity assay in patients with T2DM...
- Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention
Jonas Hallén
Department of Cardiology, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway
Am J Cardiol 105:1223-8. 2010
..7 to 23.7; c-index 0.781). In conclusion, an electrocardiogram obtained early after primary percutaneous coronary intervention analyzed by a simple algorithm provided prognostic information on the final infarct size and cardiac function...
- Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial
Jonas Hallén
Department of Cardiology, Oslo University Hospital, Aker and University of Oslo, Norway
EuroIntervention 5:946-52. 2010
..To determine whether the efficacy of FX06 was dependent upon the timing of reperfusion therapy or the presence of collaterals in the Efficacy of FX06 in the prevention of myocardial reperfusion injury (F.I.R.E.) trial...
Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experienceTrygve Sørdahl Hall
Department of Cardiology, Lovisenberg Diakonale Hospital, Oslo, Norway
Clin Lab 58:1029-36. 2012
....
